We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

GlaxoSmithKline Consumer Healthcare (Ireland) Ltd

12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland
E-mail: customer.relations@gsk.com
Medical Information Direct Line: 1800 441 442
Patient Information Leaflet last updated on medicines.ie: 12/09/2017
PIL alli 60 mg hard capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 12/09/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 1 - what the product is used for
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 4 - possible side effects
Updated on 22/04/2016 and displayed until 12/09/2017
Reasons for adding or updating:
  • Change to drug interactions
Updated on 19/02/2014 and displayed until 22/04/2016
Reasons for adding or updating:
  • Addition of marketing authorisation holder
Updated on 29/01/2013 and displayed until 19/02/2014
Reasons for adding or updating:
  • Change due to harmonisation of PIL
Updated on 24/10/2011 and displayed until 29/01/2013
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 06/04/2010 and displayed until 24/10/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
Updated on 22/05/2009 and displayed until 06/04/2010
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Orlistat